Skip to main content
NCBI home page
Gut logoLink to Gut
. 1995 Nov;37(5):630–638. doi: 10.1136/gut.37.5.630

Administration of insulin-like growth factor-I (IGF-I) peptides for three days stimulates proliferation of the small intestinal epithelium in rats.

C B Steeb 1, J F Trahair 1, L C Read 1
PMCID: PMC1382866  PMID: 8549937

Abstract

It has previously been shown that longterm administration of insulin-like growth factor-I (IGF-I) or the analogue Long R3 IGF-I (LR3IGF-I) selectively stimulate growth of the gastrointestinal tract in gut resected, dexamethasone treated, and normal rats. In this study, the short-term effects of IGF-I administration on intestinal proliferation have been investigated. Female rats (110 g, five-six/group) were infused for three days with 2.5 mg/kg/day of either IGF-I or LR3IGF-I and compared with vehicle treated or untreated control rats. LR3IGF-I but not IGF-I increased body weight and wet tissue weight of the small and large intestine (+20%), compared with controls. Tissue weight responses were independent of food intake and were reflected in the histology of the tissue. In LR3IGF-I treated animals, duodenal and ileal crypts length were increased by 13 and 22%, respectively, associated with an increase in crypt cell number. No such histological changes were seen in IGF-I treated rats. Tritiated thymidine labelling indices were significantly increased after administration of either IGF-I or LR3IGF-I (up to 14%) in both the duodenum and ileum. In IGF-I treated rats, increased nuclear labelling was not associated with an increase in the crypt compartment. In contrast, LR3IGF-I induced proportional increments in thymidine labelling and crypt size, suggesting that LR3IGF-I is not only more potent than the native peptide but also induced proliferative events more rapidly. In the colon, the thymidine labelling index was low, however, a non-significant increase in the number of cells labelled with thymidine was seen. These results suggest that within a three day treatment period intestinal mitogenesis is more advanced in animals treated with LR3IGF-I. The differences in proliferative response between the two peptides may be accounted for by variations in pharmacokinetics, clearance rates, and interactions with circulating and tissue specific binding proteins.

Full text

PDF
630

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Dewachi H. S., Wright N. A., Appleton D. R., Watson A. J. The cell cycle time in the rat jejunal mucosa. Cell Tissue Kinet. 1974 Nov;7(6):587–594. doi: 10.1111/j.1365-2184.1974.tb00442.x. [DOI] [PubMed] [Google Scholar]
  2. Ballard F. J., Walton P. E., Bastian S., Tomas F. M., Wallace J. C., Francis G. L. Effects of interactions between IGFBPs and IGFs on the plasma clearance and in vivo biological activities of IGFs and IGF analogs. Growth Regul. 1993 Mar;3(1):40–44. [PubMed] [Google Scholar]
  3. Bastian S. E., Walton P. E., Wallace J. C., Ballard F. J. Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I) and an analogue LR3IGF-I in pregnant rats. J Endocrinol. 1993 Aug;138(2):327–336. doi: 10.1677/joe.0.1380327. [DOI] [PubMed] [Google Scholar]
  4. Chaurasia O. P., Marcuard S. P., Seidel E. R. Insulin-like growth factor I in human gastrointestinal exocrine secretions. Regul Pept. 1994 Feb 24;50(2):113–119. doi: 10.1016/0167-0115(94)90026-4. [DOI] [PubMed] [Google Scholar]
  5. Chen M. C., Lee A. T., Soll A. H. Mitogenic response of canine fundic epithelial cells in short-term culture to transforming growth factor alpha and insulinlike growth factor I. J Clin Invest. 1991 May;87(5):1716–1723. doi: 10.1172/JCI115189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. D'Ercole A. J., Hill D. J., Strain A. J., Underwood L. E. Tissue and plasma somatomedin-C/insulin-like growth factor I concentrations in the human fetus during the first half of gestation. Pediatr Res. 1986 Mar;20(3):253–255. doi: 10.1203/00006450-198603000-00011. [DOI] [PubMed] [Google Scholar]
  7. Francis G. L., Ross M., Ballard F. J., Milner S. J., Senn C., McNeil K. A., Wallace J. C., King R., Wells J. R. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. J Mol Endocrinol. 1992 Jun;8(3):213–223. doi: 10.1677/jme.0.0080213. [DOI] [PubMed] [Google Scholar]
  8. Laburthe M., Rouyer-Fessard C., Gammeltoft S. Receptors for insulin-like growth factors I and II in rat gastrointestinal epithelium. Am J Physiol. 1988 Mar;254(3 Pt 1):G457–G462. doi: 10.1152/ajpgi.1988.254.3.G457. [DOI] [PubMed] [Google Scholar]
  9. Lemmey A. B., Martin A. A., Read L. C., Tomas F. M., Owens P. C., Ballard F. J. IGF-I and the truncated analogue des-(1-3)IGF-I enhance growth in rats after gut resection. Am J Physiol. 1991 Feb;260(2 Pt 1):E213–E219. doi: 10.1152/ajpendo.1991.260.2.E213. [DOI] [PubMed] [Google Scholar]
  10. Lynch S. E., Colvin R. B., Antoniades H. N. Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest. 1989 Aug;84(2):640–646. doi: 10.1172/JCI114210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. MacDonald R. S., Park J. H., Thornton W. H., Jr Insulin, IGF-1, and IGF-2 receptors in rat small intestine following massive small bowel resection. Analysis by binding, flow cytometry, and immunohistochemistry. Dig Dis Sci. 1993 Sep;38(9):1658–1669. doi: 10.1007/BF01303175. [DOI] [PubMed] [Google Scholar]
  12. Olanrewaju H., Patel L., Seidel E. R. Trophic action of local intraileal infusion of insulin-like growth factor I: polyamine dependence. Am J Physiol. 1992 Aug;263(2 Pt 1):E282–E286. doi: 10.1152/ajpendo.1992.263.2.E282. [DOI] [PubMed] [Google Scholar]
  13. Read L. C., Tomas F. M., Howarth G. S., Martin A. A., Edson K. J., Gillespie C. M., Owens P. C., Ballard F. J. Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats. J Endocrinol. 1992 Jun;133(3):421–431. doi: 10.1677/joe.0.1330421. [DOI] [PubMed] [Google Scholar]
  14. Romanus J. A., Yang Y. W., Adams S. O., Sofair A. N., Tseng L. Y., Nissley S. P., Rechler M. M. Synthesis of insulin-like growth factor II (IGF-II) in fetal rat tissues: translation of IGF-II ribonucleic acid and processing of pre-pro-IGF-II. Endocrinology. 1988 Feb;122(2):709–716. doi: 10.1210/endo-122-2-709. [DOI] [PubMed] [Google Scholar]
  15. Ryan J., Costigan D. C. Determination of the histological distribution of insulin like growth factor 1 receptors in the rat gut. Gut. 1993 Dec;34(12):1693–1697. doi: 10.1136/gut.34.12.1693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Schober D. A., Simmen F. A., Hadsell D. L., Baumrucker C. R. Perinatal expression of type I IGF receptors in porcine small intestine. Endocrinology. 1990 Feb;126(2):1125–1132. doi: 10.1210/endo-126-2-1125. [DOI] [PubMed] [Google Scholar]
  17. Termanini B., Nardi R. V., Finan T. M., Parikh I., Korman L. Y. Insulinlike growth factor I receptors in rabbit gastrointestinal tract. Characterization and autoradiographic localization. Gastroenterology. 1990 Jul;99(1):51–60. doi: 10.1016/0016-5085(90)91228-x. [DOI] [PubMed] [Google Scholar]
  18. Vanderhoof J. A., McCusker R. H., Clark R., Mohammadpour H., Blackwood D. J., Harty R. F., Park J. H. Truncated and native insulinlike growth factor I enhance mucosal adaptation after jejunoileal resection. Gastroenterology. 1992 Jun;102(6):1949–1956. doi: 10.1016/0016-5085(92)90318-s. [DOI] [PubMed] [Google Scholar]
  19. Young G. P., Taranto T. M., Jonas H. A., Cox A. J., Hogg A., Werther G. A. Insulin-like growth factors and the developing and mature rat small intestine: receptors and biological actions. Digestion. 1990;46 (Suppl 2):240–252. doi: 10.1159/000200392. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES